Celltrion Healthcare Co.

Bio & Pharma Celltrion unveils cancer medicine to expand new drug pipelines

South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...

Bio & Pharma Celltrion expands footprint in Latin America with flagship oncology drugs

South Korea’s biopharmaceutical giant Celltrion Inc. has solidified its presence in South America after winning supply contracts for its flags...

Mergers & Acquisitions Doosan enters race to acquire SK Siltron in strategic semiconductor push

South Korea’s Doosan Group has entered the bidding war for SK Siltron Co., the world’s third-largest manufacturer of semiconductor wafer...

Bio & Pharma Celltrion wins Australian approval for eye, bone disease biosimilars

Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...

Private equity Geopolitics rewrite investment playbook – and that’s an opportunity: KKR

In an era of escalating geopolitical uncertainty, the head of one of the world’s largest private equity firms sees opportunity – not ret...

Mergers & Acquisitions SK Group in talks with Hahn & Co. to sell SK Siltron

SK Inc., the holding company of SK Group, is in talks with Hahn & Co., a South Korean buyout firm, to sell SK Siltron Co., the country’s s...

Mergers & Acquisitions Hahn & Co. acquires SK Specialty for $1.8 billion

Hahn & Co., South Korea’s largest private equity firm, has finalized the acquisition of SK Specialty Co., the world’s leading produc...

Bio & Pharma Celltrion to sell autoimmune drug Stelara biosimilar at Costco in US

South Korea’s leading biosimilar drug developer Celltrion Inc. said on Monday it is set to sell Steqeyma, a biosimilar to autoimmune disease t...

Shareholder value Celltrion to cancel $140 mn in treasury shares, stock up

South Korea’s leading biosimilar drug developer Celltrion Inc. announced on Friday a plan to cancel $140 million worth of treasury shares to i...

Bio & Pharma Samsung, Celltrion lead biosimilar market in Europe, US

Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz in the antibody biosim...

Korean games Netmarble to launch new game 'RF Online Next'

Netmarble Corp., South Korea’s leading game developer, is slated to roll out “RF Online Next” on March 20, a revamp of the old tit...

Mergers & Acquisitions CHA Biotech seeks to resume healthcare unit IPO after affiliates’ merger

CHA Biotech Co., South Korea’s leading stem cell therapeutics developer, plans to resume an initial public offering of CHA Healthcare Co., a m...

Bio & Pharma Celltrion wins EU approval for autoimmune disease treatment Avtozma

Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...

Shipping & Shipbuilding HMM seeks to acquire parts of SK Shipping for $1.4 bn from Hahn & Co.

HMM Co., South Korea’s largest ocean carrier, is seeking to buy SK Shipping Co., excluding its liquefied natural gas (LNG) transportation busi...

Private equity EQT targets healthcare, technology, business service providers in Korea

EQT, the largest private equity firm in Europe, is setting its sights on healthcare, technology companies and business service providers in South Ko...

Bio & Pharma Celltrion’s Vegzelma: Most-prescribed cancer treatment in Europe

South Korea’s leading biosimilar drug developer Celltrion Inc.'s Vegzelma, a cancer drug referencing global biopharma Roche’s Avastin, h...

Bio & Pharma Partners Investment, GordonMD eye $150 mn biotech fund launch

South Korean venture capital firm Partners Investment said on Thursday it will raise up to 215.5 billion won ($150 million) in a biotech fund jointl...

Webtoons Naver Webtoon's Stagtown to be cinematized by Hollywood

South Korea's Naver Webtoon said on Thursday its horror series Stagtown, popular in the US, will be made into a movie by Hollywood.Stagtown was di...

Real estate Blackstone zooms in on hotels, warehouses in Korea

The global real estate market is poised for a recovery, led by industrial warehouses, residential facilities and data centers benefiting from declin...

Robotics LG CNS, Bear Robotics to co-develop autonomous robots

LG CNS Co., a South Korean information technology service company, said on Monday it signed a memorandum of understanding (MOU) with Bear Robotics...

Carbon neutrality KG Mobility, Phinia to co-work for hydrogen engine

South Korea's automaker KG Mobility Corp. said on Thursday it partnered with the global car aftermarket solutions company Phinia to develop hydrogen...

IPOs Celltrion seeks large-scale M&A in Q4, eyes 2027 Nasdaq debut

SAN FRANCISCO – South Korea’s leading biosimilar drug developer Celltrion Inc. seeks to acquire a domestic health food maker as early as...

Automobiles Hyundai, Kia’s green car exports hit record in 2024

Hyundai Motor Co. and its sibling Kia Corp. together shipped a record-high number of eco-friendly cars to overseas markets last year thanks to stron...

Bio & Pharma Korean drugmakers control more than half of European biosimilar market

South Korea’s two leading drugmakers, Celltrion Inc. and Samsung Bioepis Co., have achieved a significant milestone in the European biosimilar...

Mergers & Acquisitions Hahn & Co. buys SK Enpulse’s chip wafer polishing pad business

Seoul-based private equity firm Hahn & Co. has agreed to buy the chemical mechanical polishing (CMP) pads manufacturing division of SK Enpulse C...

Mergers & Acquisitions Hahn & Co. to buy controlling stake in SK’s specialty gas unit for $1.9 bn

South Korea’s private equity firm Hahn & Co. is set to acquire a controlling stake in the world’s top specialty gas producer SK Spec...

Bio & Pharma SK Bioscience, Sanofi to develop next-gen pneumococcal vaccines

South Korea's SK Bioscience Co. said on Friday it signed an expanded agreement with Sanofi to co-develop next-generation pneumococcal conjugate vacc...

Bio & Pharma Celltrion obtains approval of Steqeyma from FDA

South Korea's Celltrion Inc. said on Wednesday it received new drug submission (NDS) approval from the Food and Drug Administration (FDA) for Steq...

Bio & Pharma Celltrion BioSolutions launched to venture into CDMO

Celltrion Inc. on Tuesday launched its contract development and manufacturing organization unit Celltrion BioSolutions Co. in its foray into the CDM...

Bio & Pharma Celltrion’s 4 new biosimilars win EU approval recommendation

Celltrion Inc. is one step closer to commercializing its four new biosimilars in Europe after a committee of the European Medicines Agency (EMA) rec...